High times for German cannabis firm amid medical boom

At an undisclosed site in Germany’s Bavaria state, pharmaceutical CEO Philip Schetter opens a 75-centimeter (30-inch) thick steel door that secures his wares: vast amounts of cannabis.

See also  New research: GLP-1 receptor agonists may support nicotine cessation
Total
0
Share
Need Help?